4.7 Article

Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities

Rolando Cannalire et al.

Summary: This article discusses the urgent need to identify drugs for treating COVID-19 and other coronavirus diseases. Different strategies targeting the virus or host cells are being investigated. The article provides a comprehensive comparative analysis of SARS-CoV-2 proteases and RdRp with other coronavirus counterparts, highlighting the most promising inhibitors reported so far and potential strategies for further development.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimization

Atli Thorarensen et al.

Summary: Recent years have seen a resurgence in drug discovery efforts focused on covalent inhibitors, leading to an increase in literature reports and new therapies. The potency of covalent inhibitors is best described by time-independent kinetic parameters, with enzyme substrate concentrations being an important factor to consider.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Review Virology

Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19

Varada Anirudhan et al.

Summary: The review provides information on potential treatment strategies for COVID-19 that target the essential proteins of the virus, specifically 3CL(pro) and PLpro, which are key in inhibiting viral replication and may offer insights from previous experience with SARS-CoV.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Chemistry, Medicinal

Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies

Wayne Vuong et al.

Summary: The study demonstrates that GC376 and its derivatives are effective inhibitors of Mpro in SARS-CoV-2, with improved affinity and therapeutic index. Crystallographic analysis reveals an alternative binding pocket in M-pro and the mechanism of alternative binding induced by polar groups or a nearby methyl. Additionally, new findings on solubility and colloidal formation in aqueous media are reported, along with the use of choline to increase solubility.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Chemistry, Medicinal

What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design

Muya Xiong et al.

Summary: The emergence of various coronaviruses in recent decades has posed significant threats to global health, with the ongoing COVID-19 pandemic causing millions of infections and deaths worldwide. The 3C-like protease (3CL(pro)) is seen as a promising target for antiviral intervention due to its essential role in viral replication and its conserved structural features among different coronaviruses. Research focusing on the crystal structures of 3CL(pro) and their inhibitors aims to provide insights into inhibition mechanisms and guide future drug discovery efforts.

MEDICINAL RESEARCH REVIEWS (2021)

Article Chemistry, Medicinal

Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space

Giulia Caron et al.

Summary: An increasing number of drug discovery programs are focusing on compounds in the beyond rule of 5 (bRo5) chemical space, requiring revised paradigms of property-based drug design. A virtual event provided preliminary guidance on how to effectively discover oral drugs in the bRo5 space, emphasizing its importance as a source of new oral drugs. The speakers highlighted experimental and computational methods specifically tailored for design and optimization in this chemical space.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model

Jingxin Qiao et al.

Summary: The study designed and synthesized 32 new M-pro inhibitors containing bicycloproline, which showed inhibitory effects on SARS-CoV-2. Compounds MI-09 and MI-30 exhibited excellent antiviral activity in cell-based assays and significantly reduced lung viral loads and lung lesions in a transgenic mouse model of SARS-CoV-2 infection. Both also displayed good pharmacokinetic properties and safety in rats.

SCIENCE (2021)

Review Pharmacology & Pharmacy

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease

Hylemariam Mihiretie Mengist et al.

Summary: The review highlights the potency, safety, and pharmacokinetic profiles of potential inhibitors targeting SARS-CoV-2 M-pro, emphasizing the need for further research in COVID-19 therapeutics.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors

Andrea Citarella et al.

Summary: The uncontrolled spread of COVID-19 caused by SARS-CoV-2 in 2020-2021 had devastating impacts on health, economy, and daily life globally. Despite approved vaccines, their long-term efficacy and safety are debated, prompting the search for new target-based drugs. Strategies targeting the coronavirus's main protease, M-pro, show promise for anti-coronavirus drug development.

BIOMOLECULES (2021)

Article Biochemistry & Molecular Biology

N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer

Elena Arutyunova et al.

Summary: The main protease of SARS-CoV-2 is a high priority drug target, and GC376 has been shown to effectively inhibit it. GC376 also demonstrates reversible binding and broad specificity, making it suitable for clinical trials. The stability and thermodynamic parameters of the protease were studied, revealing insights into the physical chemical properties of viral enzymes.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Chemistry, Medicinal

Utility of Physicochemical Properties for the Prediction of Toxicological Outcomes: Takeda Perspective

Tomoya Yukawa et al.

ACS MEDICINAL CHEMISTRY LETTERS (2020)

Article Chemistry, Medicinal

Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data

Christopher P. Tinworth et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2

Merel A. T. van de Plassche et al.

CHEMBIOCHEM (2020)

Review Chemistry, Medicinal

The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020

Yuzhi Liu et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

COVID-19: Drug Targets and Potential Treatments

Carmen Gil et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease

Athri D. Rathnayake et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

Wayne Vuong et al.

NATURE COMMUNICATIONS (2020)

Article Chemistry, Medicinal

Application of Molecular Dynamics Simulations to the Design of Nucleotide Inhibitors Binding to Norovirus Polymerase

Holly Freedman et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Review Biochemistry & Molecular Biology

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

Wen Cui et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Review Chemistry, Medicinal

Covalent Inhibition in Drug Discovery

Avick Kumar Ghosh et al.

CHEMMEDCHEM (2019)

Review Endocrinology & Metabolism

Clinical Use of DPP-4 Inhibitors

Baptist Gallwitz

FRONTIERS IN ENDOCRINOLOGY (2019)

Review Biochemistry & Molecular Biology

New Directions for Protease Inhibitors Directed Drug Discovery

Yoshio Hamada et al.

BIOPOLYMERS (2016)

Article Chemistry, Medicinal

Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease

Yangyang Zhai et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Biochemical Research Methods

Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and S

Martin L. Biniossek et al.

JOURNAL OF PROTEOME RESEARCH (2011)

Review Biotechnology & Applied Microbiology

The resurgence of covalent drugs

Juswinder Singh et al.

NATURE REVIEWS DRUG DISCOVERY (2011)

Review Chemistry, Multidisciplinary

Lipophilicity and Its Relationship with Passive Drug Permeation

Xiangli Liu et al.

PHARMACEUTICAL RESEARCH (2011)

Article Chemistry, Organic

Synthesis of the optically active key intermediate of FR901483

Shigeru Ieda et al.

TETRAHEDRON LETTERS (2010)

Review Biochemistry & Molecular Biology

Glutathione: Overview of its protective roles, measurement, and biosynthesis

Henry Jay Forman et al.

MOLECULAR ASPECTS OF MEDICINE (2009)

Article Chemistry, Multidisciplinary

Web-Ice:: integrated data collection and analysis for macromolecular crystallography

A. Gonzalez et al.

JOURNAL OF APPLIED CRYSTALLOGRAPHY (2008)

Review Biotechnology & Applied Microbiology

Targeting proteases: successes, failures and future prospects

Boris Turk

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Biochemistry & Molecular Biology

Inactivation of cysteine proteases by (acyloxy)methyl ketones using S′-P′ interactions

Y Dai et al.

BIOCHEMISTRY (2000)